These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27936610)

  • 1. Dynamics of Aromatic Side Chains in the Active Site of FKBP12.
    Weininger U; Modig K; Geitner AJ; Schmidpeter PA; Koch JR; Akke M
    Biochemistry; 2017 Jan; 56(1):334-343. PubMed ID: 27936610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
    Brath U; Akke M
    J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations.
    Solomentsev G; Diehl C; Akke M
    Biochemistry; 2018 Mar; 57(9):1451-1461. PubMed ID: 29412644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate.
    Sapienza PJ; Mauldin RV; Lee AL
    J Mol Biol; 2011 Jan; 405(2):378-94. PubMed ID: 21073880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraligand hydrophobic interactions rationalize drug affinities for peptidyl-prolyl cis-trans isomerase protein.
    Bizzarri M; Marsili S; Procacci P
    J Phys Chem B; 2011 May; 115(19):6193-201. PubMed ID: 21500789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes.
    Yang CJ; Takeda M; Terauchi T; Jee J; Kainosho M
    Biochemistry; 2015 Dec; 54(47):6983-95. PubMed ID: 26561008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propagation of conformational instability in FK506-binding protein FKBP12.
    LeMaster DM; Bashir Q; Hernández G
    Biochim Biophys Acta Proteins Proteom; 2024 May; 1872(3):140990. PubMed ID: 38142946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for peptidyl-prolyl isomerization activity: a comprehensive mutational analysis of the substrate-binding cavity of FK506-binding protein 12.
    Ikura T; Ito N
    Protein Sci; 2007 Dec; 16(12):2618-25. PubMed ID: 18029417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.
    Wen H; Kang S; Song Y; Song Y; Yang HJ; Kim MH; Park S
    Arch Biochem Biophys; 2012 Jan; 517(1):37-42. PubMed ID: 22100703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of conformational transitions in the active site and 80's loop in the FK506-binding protein FKBP12.
    Mustafi SM; Brecher M; Zhang J; Li H; Lemaster DM; Hernández G
    Biochem J; 2014 Mar; 458(3):525-36. PubMed ID: 24405377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of Pathogenic Fungal FKBP12s Reveal Possible Self-Catalysis Function.
    Tonthat NK; Juvvadi PR; Zhang H; Lee SC; Venters R; Spicer L; Steinbach WJ; Heitman J; Schumacher MA
    mBio; 2016 Apr; 7(2):e00492-16. PubMed ID: 27118592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl-prolyl isomerase activity of FK506 binding protein 12 prevents tau peptide from aggregating.
    Ikura T; Ito N
    Protein Eng Des Sel; 2013 Sep; 26(9):539-46. PubMed ID: 23832849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.
    Stebbins JL; Zhang Z; Chen J; Wu B; Emdadi A; Williams ME; Cashman J; Pellecchia M
    J Med Chem; 2007 Dec; 50(26):6607-17. PubMed ID: 18038971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysing the visible conformational substates of the FK506-binding protein FKBP12.
    Mustafi SM; Chen H; Li H; Lemaster DM; Hernández G
    Biochem J; 2013 Aug; 453(3):371-80. PubMed ID: 23688288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics.
    Sich C; Improta S; Cowley DJ; Guenet C; Merly JP; Teufel M; Saudek V
    Eur J Biochem; 2000 Sep; 267(17):5342-55. PubMed ID: 10951192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the RyR1-FKBP12 interaction.
    Samsó M; Shen X; Allen PD
    J Mol Biol; 2006 Mar; 356(4):917-27. PubMed ID: 16405911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-mediated dynamic hydrogen-bonding network in the active site of Pin1.
    Barman A; Hamelberg D
    Biochemistry; 2014 Jun; 53(23):3839-50. PubMed ID: 24840168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion of a chaperone domain converts FKBP12 into a powerful catalyst of protein folding.
    Knappe TA; Eckert B; Schaarschmidt P; Scholz C; Schmid FX
    J Mol Biol; 2007 May; 368(5):1458-68. PubMed ID: 17397867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical and molecular dynamics studies of buried waters in globular proteins.
    Park S; Saven JG
    Proteins; 2005 Aug; 60(3):450-63. PubMed ID: 15937899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction.
    Linnert M; Lin YJ; Manns A; Haupt K; Paschke AK; Fischer G; Weiwad M; Lücke C
    Biochemistry; 2013 Mar; 52(12):2097-107. PubMed ID: 23418784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.